• Legend Biotech average return on tangible equity for 2024 was -36.63, a 59.96% decline from 2023.
• Legend Biotech average return on tangible equity for 2023 was -91.48, a 0.63% decline from 2022.
• Legend Biotech average return on tangible equity for 2022 was -92.06, a 20.03% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.